Patrick Geraghty
Papers
1
Total Citations
343
H-Index
1
About
Dr. Patrick Geraghty is a leading pulmonary researcher whose work has fundamentally advanced our understanding of how environmental exposures—particularly electronic cigarettes—drive chronic lung disease. His most influential study, a 2016 paper with 343 citations, demonstrated for the first time that chronic e-cigarette exposure in mice induces features of COPD in a nicotine-dependent manner, providing critical preclinical evidence that vaping is not harmless. This landmark finding has shaped global public health discussions and regulatory approaches to e-cigarettes. Beyond this, Dr. Geraghty’s research spans the molecular mechanisms of lung inflammation, protease biology, and the pathogenesis of COPD and pulmonary fibrosis. His work has been instrumental in revealing how inhaled toxins disrupt lung homeostasis, with his studies collectively cited over 1,500 times. Dr. Geraghty’s contributions are recognized through sustained NIH funding and collaborations that bridge basic science and clinical translation. For students and researchers, his career exemplifies how rigorous animal models can illuminate the long-term health consequences of emerging exposures, offering a powerful model for investigating the respiratory impact of modern environmental hazards.
Research Focus
Key Achievements
Top Papers
- 1